Advertisement
Advertisement
NVAX
Novavax Inc
11.44
USDSponsored
-1.12
-8.95%
Oct 06, 10:15 UTC -4
Open
NVAX Earnings Reports
Positive Surprise Ratio
NVAX beat 20 of 43 last estimates.
47%
Next Report
Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$74.11M
/-$0.23
Implied change from Q2 26 (Revenue/ EPS)
+30.71%
/-28.13%
Implied change from Q3 25 (Revenue/ EPS)
+5.20%
/-81.60%
Novavax Inc earnings per share and revenue
On Aug 06, 2026, NVAX reported earnings of -0.32 USD per share (EPS) for Q2 26, beating the estimate of -0.39 USD, resulting in a 18.64% surprise. Revenue reached 56.70 million, compared to an expected 53.56 million, with a 5.85% difference. The market reacted with a +0.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 74.11 million USD, implying an decrease of -28.13% EPS, and increase of 30.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nanobiotix S.A. - ADR
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.70
Surprise
-496.76%
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
Rezolute, Inc. Common Stock (NV)
Report Date
Sep 24, 2026 For Q4 26
Estimate
-$0.15
Actual
-$0.20
Surprise
-32.45%
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
$0.00
Surprise
+99.70%
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
NeuroSense Therapeutics Ltd. Ordinary Shares
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$3.26
Actual
-$2.10
Surprise
+35.66%
FAQ
What were Novavax Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Novavax Inc reported EPS of -$0.32, beating estimates by 18.64%, and revenue of $56.70M, 5.85% above expectations.
How did the market react to Novavax Inc's Q2 2026 earnings?
The stock price moved up 0.52%, changed from $7.70 before the earnings release to $7.74 the day after.
When is Novavax Inc expected to report next?
The next earning report is scheduled for Nov 05, 2026.
What are the forecasts for Novavax Inc's next earnings report?
Based on 7
analysts, Novavax Inc is expected to report EPS of -$0.23 and revenue of $74.11M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.